The most frequent MYC mutations associated with cancer are located in the codons for Thr58 and Pro59 in the NH2-terminal transactivation domain, with such mutations having been shown to stabilize c-Myc by preventing its degradation by the ubiquitin-proteasome system (Figure 3A). The gene discussed is MYC; the disease is cancer.